HERV-W Envelope Triggers Abnormal Dopaminergic Neuron Process Through DRD2/PP2A/AKT1/GSK3 for Schizophrenia Risk

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2022 Jan 22

PMID 35062349

Authors

Qiujin Yan

Xiulin Wu

Ping Zhou

Yan Zhou

Xuhang Li

Zhongchun Liu

Huawei Tan

Wei Yao

Yaru Xia

Fan Zhu

Affiliations

Soon will be listed here.

Abstract

An increasing number of studies have begun considering human endogenous retroviruses () as potential pathogenic phenomena. Our previous research suggests that HERV-W Envelope (HERV-W ENV), a HERV-W family envelope protein, is elevated in schizophrenia patients and contributes to the pathophysiology of schizophrenia. The dopamine (DA) hypothesis is the cornerstone in research and clinical practice related to schizophrenia. Here, we found that the concentration of DA and the expression of DA receptor D2 (DRD2) were significantly higher in schizophrenia patients than in healthy individuals. Intriguingly, there was a positive correlation between HERV-W ENV and DA concentration. Depth analyses showed that there was a marked consistency between HERV-W ENV and DRD2 in schizophrenia. Studies in vitro indicated that HERV-W ENV could increase the DA concentration by regulating DA metabolism and induce the expression of DRD2. Co-IP assays and laser confocal scanning microscopy indicated cellular colocalization and a direct interaction between DRD2 and HERV-W ENV. Additionally, HERV-W ENV caused structural and functional abnormalities of DA neurons. Further studies showed that HERV-W ENV could trigger the PP2A/AKT1/GSK3 pathway via DRD2. A whole-cell patch-clamp analysis suggested that HERV-W ENV enhanced sodium influx through DRD2. In conclusion, we uncovered a relationship between HERV-W ENV and the dopaminergic system in the DA neurons. Considering that GNbAC1, a selective monoclonal antibody to the MSRV-specific epitope, has been promised as a therapy for treating type 1 diabetes and multiple sclerosis (MS) in clinical trials, understanding the precise function of HERV-W ENV in the dopaminergic system may provide new insights into the treatment of schizophrenia.

Citing Articles

HERV-W Env Induces Neuron Pyroptosis via the NLRP3-CASP1-GSDMD Pathway in Recent-Onset Schizophrenia.

Jia C, Zhang M, Wu X, Zhang X, Lv Z, Zhao K Int J Mol Sci. 2025; 26(2).

PMID: 39859234 PMC: 11765033. DOI: 10.3390/ijms26020520.

Ancestral retrovirus envelope protein ERVWE1 upregulates circ_0001810, a potential biomarker for schizophrenia, and induces neuronal mitochondrial dysfunction via activating AK2.

Li W, Xue X, Li X, Wu X, Zhou P, Xia Y Cell Biosci. 2024; 14(1):138.

PMID: 39543767 PMC: 11566632. DOI: 10.1186/s13578-024-01318-1.

Treatment-resistant depression: molecular mechanisms and management.

Kajumba M, Kakooza-Mwesige A, Nakasujja N, Koltai D, Canli T Mol Biomed. 2024; 5(1):43.

PMID: 39414710 PMC: 11485009. DOI: 10.1186/s43556-024-00205-y.

HERV-W upregulation expression in bipolar disorder and schizophrenia: unraveling potential links to systemic immune/inflammation status.

Rangel S, da Silva M, Natrielli Filho D, Santos S, do Amaral J, Victor J Retrovirology. 2024; 21(1):7.

PMID: 38644495 PMC: 11034070. DOI: 10.1186/s12977-024-00640-3.

Reviving: restoring depression-like behaviour through glial cell-derived neurotrophic factor treatment in the medial prefrontal cortex.

Liu Y, Zhou X, Xue K, Sun R, Tang Y, Tang C J Psychiatry Neurosci. 2024; 49(1):E23-E34.

PMID: 38302136 PMC: 10843345. DOI: 10.1503/jpn.230079.

References

Urbanska M, Gozdz A, Macias M, Cymerman I, Liszewska E, Kondratiuk I . GSK3β Controls mTOR and Prosurvival Signaling in Neurons. Mol Neurobiol. 2017; 55(7):6050-6062. PMC: 5994211. DOI: 10.1007/s12035-017-0823-9. View

Yu H, Liu T, Zhao Z, Chen Y, Zeng J, Liu S . Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb. Oncogene. 2013; 33(30):3947-58. DOI: 10.1038/onc.2013.366. View

Rotter A, Lenz B, Pitsch R, Richter-Schmidinger T, Kornhuber J, Rhein C . Alpha-Synuclein RNA Expression is Increased in Major Depression. Int J Mol Sci. 2019; 20(8). PMC: 6515395. DOI: 10.3390/ijms20082029. View

Few W, Scheuer T, Catterall W . Dopamine modulation of neuronal Na(+) channels requires binding of A kinase-anchoring protein 15 and PKA by a modified leucine zipper motif. Proc Natl Acad Sci U S A. 2007; 104(12):5187-92. PMC: 1829284. DOI: 10.1073/pnas.0611619104. View

Yang Q, Li B, Tang J, Cui X, Wang Y, Li X . Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data. Brief Bioinform. 2019; 21(3):1058-1068. DOI: 10.1093/bib/bbz049. View

Li S, Liu Z, Yin S, Chen Y, Yu H, Zeng J . Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREB. Neuroscience. 2013; 247:164-74. DOI: 10.1016/j.neuroscience.2013.05.033. View

Lin R, Scheller R . Mechanisms of synaptic vesicle exocytosis. Annu Rev Cell Dev Biol. 2000; 16:19-49. DOI: 10.1146/annurev.cellbio.16.1.19. View

Sun X, Wei Y, Xiong Y, Wang X, Xie A, Wang X . Synaptic released zinc promotes tau hyperphosphorylation by inhibition of protein phosphatase 2A (PP2A). J Biol Chem. 2012; 287(14):11174-82. PMC: 3322889. DOI: 10.1074/jbc.M111.309070. View

Kennedy M . Signal-processing machines at the postsynaptic density. Science. 2000; 290(5492):750-4. DOI: 10.1126/science.290.5492.750. View

10.

Juan W, Huang S, Chang C, Hung Y, Lin Y, Chen T . Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal.... J Pineal Res. 2013; 56(2):213-23. DOI: 10.1111/jpi.12114. View

11.

Emamian E, Hall D, Birnbaum M, Karayiorgou M, Gogos J . Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004; 36(2):131-7. DOI: 10.1038/ng1296. View

12.

Xicoy H, Wieringa B, Martens G . The SH-SY5Y cell line in Parkinson's disease research: a systematic review. Mol Neurodegener. 2017; 12(1):10. PMC: 5259880. DOI: 10.1186/s13024-017-0149-0. View

13.

Hartung H, Derfuss T, Cree B, Sormani M, Selmaj K, Stutters J . Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study. Mult Scler. 2021; 28(3):429-440. DOI: 10.1177/13524585211024997. View

14.

Steffen M, Seay C, Amini B, Cai Y, Feigenspan A, Baxter D . Spontaneous activity of dopaminergic retinal neurons. Biophys J. 2003; 85(4):2158-69. PMC: 1303443. DOI: 10.1016/S0006-3495(03)74642-6. View

15.

Barnes M, Huxley-Jones J, Maycox P, Lennon M, Thornber A, Kelly F . Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. J Neurosci Res. 2011; 89(8):1218-27. DOI: 10.1002/jnr.22647. View

16.

Hur E, Zhou F . GSK3 signalling in neural development. Nat Rev Neurosci. 2010; 11(8):539-51. PMC: 3533361. DOI: 10.1038/nrn2870. View

17.

Perron H, Mekaoui L, Bernard C, Veas F, Stefas I, Leboyer M . Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol Psychiatry. 2008; 64(12):1019-23. DOI: 10.1016/j.biopsych.2008.06.028. View

18.

Vaughan R, Foster J . Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol Sci. 2013; 34(9):489-96. PMC: 3831354. DOI: 10.1016/j.tips.2013.07.005. View

19.

Rampino A, Di Carlo P, Fazio L, Ursini G, Pergola G, De Virgilio C . Association of functional genetic variation in PP2A with prefrontal working memory processing. Behav Brain Res. 2016; 316:125-130. DOI: 10.1016/j.bbr.2016.08.054. View

20.

Cardozo D . Midbrain dopaminergic neurons from postnatal rat in long-term primary culture. Neuroscience. 1993; 56(2):409-21. DOI: 10.1016/0306-4522(93)90342-d. View